Study S001752

A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Subcutaneous Injections of HRS-4729 Injection in Healthy Subjects

ClinicalTrials.gov record

Registration

Registration: NCT06762600
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 102
Start: 2025-01-16
Primary completion: 2026-03-12
Lead sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions: Overweight or Obesity
Interventions: DRUG:HRS-4729 injection; DRUG:HRS-4729 injection placebo; DRUG:HRS9531 injection; DRUG:HRS9531 injection placebo; DRUG:Acetaminophen
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Adverse events (AEs) [Screening period up to day 43.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.